Cargando…

Coagulation Factor Xa

The third edition of the Handbook of Proteolytic Enzymes aims to be a comprehensive reference work for the enzymes that cleave proteins and peptides, and contains over 800 chapters. Each chapter is organized into sections describing the name and history, activity and specificity, structural chemistr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Mark A., Stenberg, Leisa M., Stenflo, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149769/ http://dx.doi.org/10.1016/B978-0-12-382219-2.00642-6

Ejemplares similares

Roles of factor Xa beyond coagulation
por: Ruf, Wolfram
Publicado: (2021)

Thrombin and factor Xa link the coagulation system with liver fibrosis
por: Dhar, Ameet, et al.
Publicado: (2018)

Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays
por: Artim-Esen, Bahar, et al.
Publicado: (2015)

Antiplatelet Aggregation Properties of Cirsilineol: A Novel Inhibitor of Blood Coagulation Factor Xa
por: Kim, Go Oun, et al.
Publicado: (2023)

Molecular Dynamics Simulation Study of the Selective Inhibition of Coagulation Factor IXa over Factor Xa
por: Yoon, Hyun Jung, et al.
Publicado: (2023)

Blood flow controls coagulation onset via the positive feedback of factor VII activation by factor Xa
por: Shibeko, Alexey M, et al.
Publicado: (2010)

Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice
por: Posthuma, Jelle J., et al.
Publicado: (2019)

Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation
por: Arce, Maximiliano, et al.
Publicado: (2019)

Differential Assessment of Factor Xa Activity and Global Blood Coagulability Utilizing Novel Dielectric Coagulometry
por: Hamada, Satomi, et al.
Publicado: (2018)

Thermodynamics of Water in an Enzyme Active Site: Grid-Based Hydration Analysis of Coagulation Factor Xa
por: Nguyen, Crystal N., et al.
Publicado: (2014)

Correction of the coagulation defect in hemophilia using a factor Xa variant with novel engineered protease function
por: Ivanciu, Lacramioara, et al.
Publicado: (2011)

Coagulation Factor Xa Induces Proinflammatory Responses in Cardiac Fibroblasts via Activation of Protease-Activated Receptor-1
por: D’Alessandro, Elisa, et al.
Publicado: (2021)

Parallel imaging of coagulation pathway proteases activated protein C, thrombin, and factor Xa in human plasma
por: Modrzycka, Sylwia, et al.
Publicado: (2022)

Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors
por: Verhoef, Daniël, et al.
Publicado: (2017)

The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents
por: Frydman, Galit H., et al.
Publicado: (2020)

Factor Xa Inhibition Reduces Coagulation Activity but Not Inflammation Among People With HIV: A Randomized Clinical Trial
por: Baker, Jason V, et al.
Publicado: (2020)

The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm
por: Borensztajn, Keren, et al.
Publicado: (2010)

Author Correction: Differential Assessment of Factor Xa Activity and Global Blood Coagulability Utilizing Novel Dielectric Coagulometry
por: Hamada, Satomi, et al.
Publicado: (2019)

Protein‐Templated Formation of an Inhibitor of the Blood Coagulation Factor Xa through a Background‐Free Amidation Reaction
por: Jaegle, Mike, et al.
Publicado: (2017)

Functional assembly of intrinsic coagulation proteases on monocytes and platelets. Comparison between cofactor activities induced by thrombin and factor Xa
Publicado: (1992)

Coagulation Factor Xa (Recombinant), Inactivated-Zhzo (Andexanet Alfa) Hemostatic Outcomes and Thrombotic Event Incidence at an Academic Medical Center
por: Stevens, Victoria M., et al.
Publicado: (2019)

Rivaroxaban‐calibrated chromogenic anti‐Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation
por: Lucas, Fabienne, et al.
Publicado: (2021)

Mechanism of Protein-Z-Mediated Inhibition of Coagulation Factor Xa by Z-Protein-Dependent Inhibitor: A Molecular Dynamic Approach
por: Dayer, Mohammad Reza, et al.
Publicado: (2012)

The new factor Xa inhibitor: Apixaban
por: Bhanwra, Sangeeta, et al.
Publicado: (2014)

Measuring residual anti‐Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa
por: Bourdin, Matthieu, et al.
Publicado: (2021)

Theoretical Study of Molecular Structure and Physicochemical Properties of Novel Factor Xa Inhibitors and Dual Factor Xa and Factor IIa Inhibitors
por: Remko, Milan, et al.
Publicado: (2016)

An XA21-Associated Kinase (OsSERK2) Regulates Immunity Mediated by the XA21 and XA3 Immune Receptors
por: Chen, Xuewei, et al.
Publicado: (2014)

Pharmacodynamics and Pharmacokinetics of oral factor Xa inhibitors
por: Persson, Pontus B
Publicado: (2015)

Xa tantlin lisantiago /
por: Ibarra, José Xochihua
Publicado: (1993)

Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear
por: Berny, Michelle A., et al.
Publicado: (2010)

Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A(2 )by affinity binding studies and molecular bioinformatics
por: Faure, Grazyna, et al.
Publicado: (2007)

Rivaroxaban, a Direct Oral Factor Xa Inhibitor, Attenuates Atherosclerosis by Alleviating Factor Xa–PAR2-Mediated Autophagy Suppression
por: Ito, Yusuke, et al.
Publicado: (2021)

The Development of New Factor Xa Inhibitors Based on Amide Synthesis
por: Tarasov, Dmitry N., et al.
Publicado: (2018)

Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor
por: Bounameaux, Henri, et al.
Publicado: (2014)

Marker-aided Incorporation of Xa38, a Novel Bacterial Blight Resistance Gene, in PB1121 and Comparison of its Resistance Spectrum with xa13 + Xa21
por: Ellur, Ranjith K., et al.
Publicado: (2016)

The role of factor Xa inhibitors in venous thromboembolism treatment
por: Cabral, Katherine P, et al.
Publicado: (2015)

Discovery and development of Factor Xa inhibitors (2015–2022)
por: Zheng, Wei, et al.
Publicado: (2023)

Application of Molecular Modeling to Development of New Factor Xa Inhibitors
por: Sulimov, Vladimir B., et al.
Publicado: (2015)

An experiment with VM/XA share
por: Pope, B G
Publicado: (1990)

Preclinical and clinical data for factor Xa and “universal” reversal agents(,,)
por: Milling, Truman J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k0jlcopp8gk3oo8nqu4vc1imhd